You are here : FHU-SEPSISENOBJECTIVES & PROJECTSPartnership
- Partager cette page :
- PDF version
Partnership
Hospitals
 |
 |
| Ambroise Paré ICU, Adult ER, Nephrology Hemodialysis, Hematology Immunology, Microbiology and Hygiene, Epidemiology Public Health |
| André Mignot ICU |
| Bicêtre ICU, Pediatric ICU |
| Lariboisière ICU |
| Raymond Poincaré ICU, Pediatric Neurology and ICU, Pharmacology Toxicology, Microbiology and Hygiene, Imaging, Epidemiology Public Health |
Public Research Institutes
 |
 |
 |
 |
 |
 |
| List CEA |
| U1173 Infection & Inflammation UVSQ Paris-Saclay, Inserm |
| U1181 Pharmacoépidémiologie et maladies infectieuses UVSQ Paris-Saclay, Inserm, Institut Pasteur |
| Laboratoire DAVID - ADAM UVSQ Paris-Saclay |
| U8100 Laboratoire de Mathématique de Versailles UVSQ Paris-Saclay, CNRS |
| I2BC - Host Pathogen Interactions in Human Sepsis Université Paris-Saclay, CNRS, CEA |
| U8612 Institut Galien Université Paris-Saclay, CNRS |
Industries
| Biothelis
Expert in endocan dosage, this French company offers a dosage kit for in-vitro diagnosis and reagents for research. |
 |
| Easy Life Science (ELICE)
A French company created in 2009, ELICE develops and commercializes innovative research instruments in the molecular biology field. |
 |
| OBS Medical
This English company develops predictive algorithms to identify the risk factors in patients and improve prevention. |
 |
| Specific Diagnostics
Is a California-based company providing best-in-class rapid antimicrobial susceptibility testing with extended MIC determination, directly from a positive blood-culture or from an isolate. |
 |
Scientist Interest Group
| EPI-PHARE
Created by ANSM and CNAM, EPI-PHARE conducts pharmaco-epidemiology studies based on the French National Health Data System (SNDS) to enlighten public authorities in their decision-making. |
 |